DNER and cancer: Novel derivatives of 7-methylimidazopyrazinone synthesized by Yang et al. were evaluated for their activity against BET proteins and for their activity against a lymphoblast-like cell line (Raji), a leukemia cell line (HL-60), and a human pancreatic (BxPC-3) cancer cell line [140].